Aseko
Greenville, US · Delaware corporation
Find your way into Aseko
Sign up to see every warm intro you have to Aseko
- Paths you didn't know you had: your email and LinkedIn already hold routes to the Aseko team. We find them for you
- 2nd- and 3rd-degree connections: the friend-of-a-friend routes that take hours to manually find through your inbox or LinkedIn
- Answers now, not in days: momentum is everything in a raise. Skip asking around whether someone knows someone
Days of research, done the moment you sign in, with every route ranked by how warm it is.
Founders & leadership
DF
Daniel FrankExecutive
RL
Robert LeonardExecutive
JD
Joseph DiverExecutive
RB
Robby BoothExecutive
RM
Raymie McFarlandExecutive
JB
John BenekeExecutive
RH
Randy HawkinsExecutive
PF
Patrick F CuaExecutive
MM
Matthew McPhersonExecutive
Board
MO
Molly O'NeillBoard director
LV
Lynn VogelBoard director
SG
Scott GottliebBoard director
Reported raises · per SEC filings
Form D private placements$64.5M disclosed across 10 rounds · 2014–2024
▶$10MraisedSep 2026 · 17 investors · Other TechnologyRule 506(b)
▶$10MraisedSep 2026 · 17 investors · Other Technology
Rule 506(b)Officers, directors & promoters on the filing
- Patrick F CuaExecutive Officer, Director
- Andrew R MidlerDirector
- Deborah DeanDirector
- Bruce BodeDirector
- Matthew McPhersonExecutive Officer
- Offering amount
- $10M
- Amount sold
- $10M
- Minimum investment
- $1
- First sale
- Dec 2024
- Incorporated
- Corporation, Delaware
- Federal exemptions
- 06b
▶$19.4MraisedAug 2023 · 22 investors · Other Health CareRule 506(b)
▶$19.4MraisedAug 2023 · 22 investors · Other Health Care
Rule 506(b)Officers, directors & promoters on the filing
- Edmond FurlongExecutive Officer, Director
- Andrew MidlerExecutive Officer, Director
- Stephen WallackExecutive Officer
- Daniel FrankDirector
- Patrick CuaDirector
- Deborah DeanDirector
- Amount sold
- $19.4M
- First sale
- Oct 2022
- Incorporated
- Corporation, Delaware
- Federal exemptions
- 06b
▶$6MraisedMay 2020 · 27 investors · Other Health CareRule 506(b)
▶$6MraisedMay 2020 · 27 investors · Other Health Care
Rule 506(b)Officers, directors & promoters on the filing
- Daniel FrankDirector
- Patrick CuaDirector
- Deborah DeanDirector
- Edmond FurlongExecutive Officer, Director
- Andrew MidlerExecutive Officer, Director
- Stephen WallackExecutive Officer
- Offering amount
- $12M
- Amount sold
- $6M
- First sale
- May 2020
- Incorporated
- Corporation, Delaware
- Federal exemptions
- 06b
▶$6.4MraisedOct 2019 · 21 investors · Other Health CareRule 506(b)
▶$6.4MraisedOct 2019 · 21 investors · Other Health Care
Rule 506(b)Officers, directors & promoters on the filing
- Andrew MidlerExecutive Officer, Director
- John BenekeExecutive Officer
- Edmond FurlongExecutive Officer, Director
- Deborah DeanDirector
- Patrick CuaDirector
- Daniel FrankDirector
- Offering amount
- $17.1M
- Amount sold
- $6.4M
- First sale
- Jul 2019
- Incorporated
- Corporation, Delaware
- Federal exemptions
- 06b
▶$1.4MraisedJul 2019 · 13 investors · Other Health CareRule 506(b)
▶$1.4MraisedJul 2019 · 13 investors · Other Health Care
Rule 506(b)Officers, directors & promoters on the filing
- Andrew MidlerDirector
- Paul FulchinoDirector
- Edward FloydDirector
- Lynn VogelDirector
- Jay FleischmanDirector
- Daniel FrankExecutive Officer, Director
- Robert LeonardExecutive Officer, Director
- Patrick CuaDirector
- Megan PietropaoloExecutive Officer
- John BenekeExecutive Officer
- Offering amount
- $2M
- Amount sold
- $1.4M
- First sale
- Jul 2019
- Incorporated
- Corporation, Delaware
- Federal exemptions
- 06b
▶$4.7MraisedApr 2018 · 23 investors · Other Health CareRule 506(b)
▶$4.7MraisedApr 2018 · 23 investors · Other Health Care
Rule 506(b)Officers, directors & promoters on the filing
- Paul FulchinoDirector
- Robert BoothExecutive Officer
- Jay FleischmanDirector
- Phil TorrenceExecutive Officer
- Robert LeonardExecutive Officer, Director
- Edward FloydDirector
- Patrick CuaDirector
- John BenekeExecutive Officer
- Andrew MidlerDirector
- Lynn VogelDirector
- Megan PietropaoloExecutive Officer
- Daniel FrankExecutive Officer, Director
- Offering amount
- $5M
- Amount sold
- $4.7M
- Minimum investment
- $6K
- First sale
- Mar 2018
- Incorporated
- Corporation, Delaware
- Federal exemptions
- 06b
▶$4.1MraisedJun 2017 · 33 investors · Other Health CareRule 506(b)
▶$4.1MraisedJun 2017 · 33 investors · Other Health Care
Rule 506(b)Officers, directors & promoters on the filing
- Andrew MidlerDirector
- John BenekeExecutive Officer
- Patrick CuaDirector
- Lynn VogelDirector
- Megan PietropaoloExecutive Officer
- Robert LeonardExecutive Officer, Director
- Cheryl PegusDirector
- Paul FulchinoDirector
- Daniel FrankExecutive Officer, Director
- Robert BoothExecutive Officer
- Edward FloydDirector
- Phillip D. TorrenceExecutive Officer
- Offering amount
- $4.1M
- Amount sold
- $4.1M
- Minimum investment
- $5K
- First sale
- May 2017
- Incorporated
- Corporation, Delaware
- Federal exemptions
- 06b
▶$5MraisedMar 2016 · 36 investors · Other Health CareRule 506(b)
▶$5MraisedMar 2016 · 36 investors · Other Health Care
Rule 506(b)Officers, directors & promoters on the filing
- John BenekeExecutive Officer
- Robert LeonardExecutive Officer, Director
- Cheryl PegusDirector
- Robby BoothExecutive Officer
- Raymie McFarlandExecutive Officer
- Tim A. FischellDirector
- Joseph DiverExecutive Officer
- Lynn VogelDirector
- Phillip D. TorrenceExecutive Officer
- Paul FulchinoDirector
- Molly O'NeillDirector
- Scott GottliebDirector
- Daniel FrankExecutive Officer, Director
- Megan PietropaoloExecutive Officer
- Offering amount
- $5M
- Amount sold
- $5M
- Minimum investment
- $6.5K
- First sale
- Mar 2016
- Incorporated
- Corporation, Delaware
- Federal exemptions
- 06b
Source: SEC EDGAR Form D. Amounts as filed; amended filings shown once at their latest values.
Frequently asked questions
- How much funding has Aseko raised?
- Aseko has disclosed $64.5M raised across 10 rounds.
- Where is Aseko headquartered?
- Aseko is headquartered in Greenville, US.